Antioxidant levels in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at antioxidant levels in people with type 2 diabetes to understand how inflammation and diabetes affect them. If you have diabetes and recent blood test results, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have type 2 diabetes.
- You need to have had blood tests done by a doctor within the last month.
- You must be willing to take part voluntarily.
- You cannot have an active infection or inflammatory condition.
- You cannot have advanced kidney or liver failure, active cancer, or be on chemotherapy/radiotherapy.
- You cannot be pregnant or breastfeeding.
- You cannot be taking antioxidant or vitamin-mineral supplements.
- You cannot be on special diets like keto, time-restricted, or elimination diets.
- You must not have severe memory or communication problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why people with type 2 diabetes develop heart problems. Researchers will examine special cells in your blood and inflammation markers to better understand these complications.
This trial tests whether an anti-inflammatory diet can help people with type 2 diabetes. You will follow a special meal plan and have regular checkups to see how it affects your blood sugar and overall health.
This study looks at how inflammation relates to complications in people with type 2 diabetes. It is an observational study, meaning you don't receive any treatment — the goal is to understand the connection better.
This study looks at how platelets (the cells that help blood clot) may be affected in people with type 2 diabetes. It aims to understand if diabetes changes platelet function, which could help improve heart health in the future.
This study looks at whether certain blood markers (uric acid and cholesterol-related ratios) are linked to diabetes complications. It may help doctors better understand and manage type 2 diabetes.
This trial tests whether taking omega-3 fatty acids can reduce risk factors for developing diabetes in people with normal cholesterol but other risk factors. You might be asked to follow study visits and dietary/health restrictions for about 33 weeks.
Hear when a new Inflamation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.